Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Table of Contents

August 15, 2022; Volume 19,Issue 8
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Bai, Weiyu

    1. You have access
      PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas
      Junling Shen, Jilong Yang, Lei Sang, Rui Sun, Weiyu Bai, Chao Wang, Yan Sun and Jianwei Sun
      Cancer Biology & Medicine August 2022, 19 (8) 1211-1223; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0294
  2. Bai, Wenqi

    1. You have access
      Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
      Yan Li, Lihong Fan, Jianming Zheng, Xiu Nie, Yu Sun, Qin Feng, Shenyi Lian, Wenqi Bai, Weijing Cai, Yanan Yang, Bo Su, Yanfeng Xi and Dongmei Lin
      Cancer Biology & Medicine August 2022, 19 (8) 1235-1248; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0585
  3. Cai, Weijing

    1. You have access
      Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer
      Yan Li, Lihong Fan, Jianming Zheng, Xiu Nie, Yu Sun, Qin Feng, Shenyi Lian, Wenqi Bai, Weijing Cai, Yanan Yang, Bo Su, Yanfeng Xi and Dongmei Lin
      Cancer Biology & Medicine August 2022, 19 (8) 1235-1248; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0585
  4. Cai, Wenli

    1. You have access
      Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer
      Qiong Wang, Zean Li, Jin Yang, Shirong Peng, Qianghua Zhou, Kai Yao, Wenli Cai, Zhongqiu Xie, Fujun Qin, Hui Li, Xu Chen, Kaiwen Li and Hai Huang
      Cancer Biology & Medicine August 2022, 19 (8) 1193-1210; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0550
  5. Cao, Maomao

    1. You have access
      Current cancer burden in China: epidemiology, etiology, and prevention
      Maomao Cao, He Li, Dianqin Sun, Siyi He, Xinxin Yan, Fan Yang, Shaoli Zhang, Changfa Xia, Lin Lei, Ji Peng and Wanqing Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1121-1138; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0231
  6. Chen, Chong

    1. You have access
      Epigenetic reprogramming in small cell lung cancer
      Jingyao Chen, Xiangyu Pan, Feifei Na, Xuelan Chen and Chong Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1111-1116; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0343
  7. Chen, Huan

    1. You have access
      Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
      Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
      Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708
  8. Chen, Jingyao

    1. You have access
      Epigenetic reprogramming in small cell lung cancer
      Jingyao Chen, Xiangyu Pan, Feifei Na, Xuelan Chen and Chong Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1111-1116; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0343
  9. Chen, Wanqing

    1. You have access
      Current cancer burden in China: epidemiology, etiology, and prevention
      Maomao Cao, He Li, Dianqin Sun, Siyi He, Xinxin Yan, Fan Yang, Shaoli Zhang, Changfa Xia, Lin Lei, Ji Peng and Wanqing Chen
      Cancer Biology & Medicine August 2022, 19 (8) 1121-1138; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0231
  10. Chen, Xinrui

    1. You have access
      Update on diffuse large B-cell lymphoma: highlights from the 2022 ASCO Annual Meeting
      Minghan Qiu, Shan Wu, Xinrui Chen and Huaqing Wang
      Cancer Biology & Medicine August 2022, 19 (8) 1117-1120; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0403
« Previous (Pages : 1 2 3 4 5 6 ... 13) Next »
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 19 (8)
Cancer Biology & Medicine
Vol. 19, Issue 8
15 Aug 2022
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire